Ocular-specific ER stress reduction rescues glaucoma in murine glucocorticoid-induced glaucoma

Journal of Clinical Investigation

Volumn 124, Issue 5, 2014, Pages 1956-1965

  Zode, Gulab S ^a,c   Sharma, Arti B ^a   Lin, Xiaolei ^a   Searby, Charles C ^a,b   Bugge, Kevin ^a,b   Kim, Gun Hee ^a   Clark, Abbot F ^c   Sheffield, Val C ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHENYLBUTYRIC ACID; DEXAMETHASONE; GLUCOCORTICOID; TRANSCRIPTION FACTOR; TRANSCRIPTIONAL FACTOR CHOP; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR EYE SEGMENT; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; GLAUCOMA; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MOUSE; NERVE FIBER DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RETINA GANGLION CELL; TRABECULAR MESHWORK;

ANIMALS; ANTINEOPLASTIC AGENTS; DEXAMETHASONE; DISEASE MODELS, ANIMAL; ENDOPLASMIC RETICULUM STRESS; GENE DELETION; GLAUCOMA, OPEN-ANGLE; GLUCOCORTICOIDS; HUMANS; MICE; MICE, TRANSGENIC; PHENYLBUTYRATES; TRABECULAR MESHWORK; TRANSCRIPTION FACTOR CHOP;

EID: 84899764084     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI69774     Document Type: Article

References (55)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80(5):389-393.
2. Quigley HA. Neuronal death in glaucoma. Prog Retin Eye Res. 1999;18(1):39-57.
3. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262-267.
4. Kwon YH, Fingert JH, Kuehn MH, Alward WL. Primary open-angle glaucoma. N Engl J Med. 2009; 360(11):1113-1124.
5. Libby RT, Gould DB, Anderson MG, John SW. Complex genetics of glaucoma susceptibility. Annu Rev Genomics Hum Genet. 2005;6:15-44.
6. Leske MC, et al. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121(1):48-56.
7. Gordon MO, et al. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):714-720.
8. Rohen JW, Lutjen-Drecoll E, Flugel C, Meyer M, Grierson I. Ultrastructure of the trabecular meshwork in untreated cases of primary open-angle glaucoma (POAG). Exp Eye Res. 1993;56(6):683-692.
9. Bill A. Editorial: The drainage of aqueous humor. Invest Ophthalmol. 1975;14(1):1-3.
10. Armaly MF, Becker B. Intraocular pressure response to topical corticosteroids. Fed Proc. 1965; 24(6):1274-1278.
11. Becker B. Intraocular pressure response to topical corticosteroids. Invest Ophthalmol. 1965;4(2):198-205.
12. Becker B, Mills DW. Corticosteroids and intraocular pressure. Arch Ophthalmol. 1963;70:500-507.
13. Bernstein HN, Mills DW, Becker B. Steroid-induced elevation of intraocular pressure. Arch Ophthalmol. 1963;70:15-18.
14. Clark AF, Wordinger RJ. The role of steroids in outflow resistance. Exp Eye Res. 2009;88(4):752-759.
15. Kersey JP, Broadway DC. Corticosteroid-induced glaucoma: a review of the literature. Eye (Lond). 2006; 20(4):407-416.
16. Jones R, Jones R 3rd, Rhee DJ. Corticosteroidinduced ocular hypertension and glaucoma: a brief review and update of the literature. Curr Opin Ophthalmol. 2006;17(2):163-167.
17. Wordinger RJ, Clark AF. Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma. Prog Retin Eye Res. 1999; 18(5):629-667.
18. Armaly MF. Effect of corticosteroids on intraocular pressure and fluid dynamics. II. The effect of dexamethasone in the glaucomatous eye. Arch Ophthalmol. 1963;70:492-499.
19. Schroder M, Kaufman RJ. The mammalian unfolded protein response. Annu Rev Biochem. 2005;74:739-789.
20. Yoshida H. ER stress and diseases. FEBS J. 2007; 274(3):630-658.
21. Yoshida H. [Molecular biology of the ER stress response]. Seikagaku. 2004;76(7):617-630.
22. Marciniak SJ, Ron D. Endoplasmic reticulum stress signaling in disease. Physiol Rev. 2006; 86(4):1133-1149.
23. Zinszner H, et al. CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev. 1998; 12(7):982-995.
24. Yamaguchi H, Wang HG. CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells. J Biol Chem. 2004;279(44):45495-45502.
25. Oyadomari S, Mori M. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 2004;11(4):381-389.
26. Zode GS, et al. Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma. J Clin Invest. 2011;121(9):3542-3553.
27. Zode GS, et al. Topical ocular sodium 4-phenylbutyrate rescues glaucoma in a myocilin mouse model of primary open angle glaucoma. Invest Ophthalmol Vis Sci. 2012;53(3):1557-1565.
28. Rohen JW, Linner E, Witmer R. Electron microscopic studies on the trabecular meshwork in two cases of corticosteroid-glaucoma. Exp Eye Res. 1973; 17(1):19-31.
29. Johnson D, Gottanka J, Flugel C, Hoffmann F, Futa R, Lutjen-Drecoll E. Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids. Arch Ophthalmol. 1997; 115(3):375-383.
30. Stamer WD, Hoffman EA, Kurali E, Krauss AH. Unique response profile of trabecular meshwork cells to the novel selective glucocorticoid receptor agonist, GW870086X. Invest Ophthalmol Vis Sci. 2013; 54(3):2100-2107.
31. Linssen MM, et al. Prednisolone-induced cell dysfunction is associated with impaired endoplasmic reticulum homeostasis in INS-1E cells. Cell Signal. 2011;23(11):1708-1715.
32. Anderson MG, Libby RT, Gould DB, Smith RS, John SW. High-dose radiation with bone marrow transfer prevents neurodegeneration in an inherited glaucoma. Proc Natl Acad Sci U S A. 2005;102(12):4566-4571.
33. Clark AF, et al. Dexamethasone alters F-actin architecture and promotes cross-linked actin network formation in human trabecular meshwork tissue. Cell Motil Cytoskeleton. 2005;60(2):83-95.
34. Steely HT, Browder SL, Julian MB, Miggans ST, Wilson KL, Clark AF. The effects of dexamethasone on fibronectin expression in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1992; 33(7):2242-2250.
35. Clark AF, et al. Glucocorticoid induction of the glaucoma gene MYOC in human and monkey trabecular meshwork cells and tissues. Invest Ophthalmol Vis Sci. 2001;42(8):1769-1780.
36. Shepard AR, Jacobson N, Fingert JH, Stone EM, Sheffield VC, Clark AF. Delayed secondary glucocorticoid responsiveness of MYOC in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2001; 42(13):3173-3181.
37. Jain A, Wordinger RJ, Yorio T, Clark AF. Spliceosome protein (SRp) regulation of glucocorticoid receptor isoforms and glucocorticoid response in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2012;53(2):857-866.
38. Sihota R, Konkal VL, Dada T, Agarwal HC, Singh R. Prospective, long-term evaluation of steroidinduced glaucoma. Eye. 2008;22(1):26-30.
39. Song B, Scheuner D, Ron D, Pennathur S, Kaufman RJ. Chop deletion reduces oxidative stress, improves beta cell function, and promotes cell survival in multiple mouse models of diabetes. J Clin Invest. 2008;118(10):3378-3389.
40. Ariyama Y, et al. Chop-deficient mice showed increased adiposity but no glucose intolerance. Obesity (Silver Spring). 2007;15(7):1647-1656.
41. Fingert JH, et al. Evaluation of the myocilin (MYOC) glaucoma gene in monkey and human steroid-induced ocular hypertension. Invest Ophthalmol Vis Sci. 2001;42(1):145-152.
42. Gerometta R, et al. Steroid-induced ocular hypertension in normal cattle. Arch Ophthalmol. 2004; 122(10):1492-1497.
43. Zhan GL, Miranda OC, Bito LZ. Steroid glaucoma: corticosteroid-induced ocular hypertension in cats. Exp Eye Res. 1992;54(2):211-218.
44. Lorenzetti OJ. Effects of corticosteroids on ocular dynamics in rabbits. J Pharmacol Exp Ther. 1970; 175(3):763-772.
45. Gerometta R, Podos SM, Danias J, Candia OA. Steroid- induced ocular hypertension in normal sheep. Invest Ophthalmol Vis Sci. 2009;50(2):669-673.
46. Sawaguchi K, Nakamura Y, Nakamura Y, Sakai H, Sawaguchi S. Myocilin gene expression in the trabecular meshwork of rats in a steroid-induced ocular hypertension model. Ophthalmic Res. 2005; 37(5):235-242.
47. Whitlock NA, McKnight B, Corcoran KN, Rodriguez LA, Rice DS. Increased intraocular pressure in mice treated with dexamethasone. Invest Ophthalmol Vis Sci. 2010;51(12):6496-6503.
48. Mao W, Tovar-Vidales T, Yorio T, Wordinger RJ, Clark AF. Perfusion-cultured bovine anterior segments as an ex vivo model for studying glucocorticoid- induced ocular hypertension and glaucoma. Invest Ophthalmol Vis Sci. 2011;52(11):8068-8075.
49. Zhang XY, Clark AF, Yorio T. Regulation of glucocorticoid responsiveness in glaucomatous trabecular meshwork cells by glucocorticoid receptor?. Invest Ophthalmol Vis Sci. 2005;46(12):4607-4616.
50. Kumar S, Shah S, Deutsch ER, Tang HM, Danias J. Triamcinolone acetonide decreases outflow facility in C57BL/6 mouse eyes. Invest Ophthalmol Vis Sci. 2013;54(2):1280-1287.
51. Marciniak SJ, et al. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev. 2004; 18(24):3066-3077.
52. Gould DB, et al. Genetically increasing Myoc expression supports a necessary pathologic role of abnormal proteins in glaucoma. Mol Cell Biol. 2004; 24(20):9019-9025.
53. Shepard AR, et al. Glaucoma-causing myocilin mutants require the peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure. Hum Mol Genet. 2007;16(6):609-617.
54. Yam GH, Gaplovska-Kysela K, Zuber C, Roth J. Sodium 4-phenylbutyrate acts as a chemical chaperone on misfolded myocilin to rescue cells from endoplasmic reticulum stress and apoptosis. Invest Ophthalmol Vis Sci. 2007;48(4):1683-1690.
55. He L, et al. ATM blocks tunicamycin-induced endoplasmic reticulum stress. FEBS Lett. 2009; 583(5):903-908.